UniSa - IRIS Institutional Research Information System

PELLECCHIA, Maria Teresa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 15.241
NA - Nord America 8.049
EU - Europa 3.126
SA - Sud America 1.015
OC - Oceania 89
AF - Africa 79
Continente sconosciuto - Info sul continente non disponibili 2
Totale 27.601
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 11.003
US - Stati Uniti d'America 7.874
SG - Singapore 2.039
CN - Cina 1.005
BR - Brasile 828
IT - Italia 729
VN - Vietnam 547
UA - Ucraina 524
RU - Federazione Russa 523
DE - Germania 309
IE - Irlanda 283
SE - Svezia 190
KR - Corea 188
TR - Turchia 177
FI - Finlandia 137
GB - Regno Unito 121
CA - Canada 92
AR - Argentina 81
IN - India 79
PL - Polonia 55
AU - Australia 49
MX - Messico 49
NL - Olanda 43
JP - Giappone 41
AT - Austria 40
EE - Estonia 38
NZ - Nuova Zelanda 36
CZ - Repubblica Ceca 31
BD - Bangladesh 30
EC - Ecuador 28
ES - Italia 24
FR - Francia 24
ZA - Sudafrica 22
ID - Indonesia 17
IL - Israele 17
IQ - Iraq 17
CO - Colombia 15
VE - Venezuela 15
PE - Perù 14
PY - Paraguay 14
CL - Cile 11
PK - Pakistan 11
JM - Giamaica 10
UZ - Uzbekistan 10
LT - Lituania 8
MA - Marocco 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
UY - Uruguay 7
GR - Grecia 6
KE - Kenya 6
SA - Arabia Saudita 6
AZ - Azerbaigian 5
BE - Belgio 5
DO - Repubblica Dominicana 5
NP - Nepal 5
TW - Taiwan 5
BG - Bulgaria 4
DZ - Algeria 4
ET - Etiopia 4
JO - Giordania 4
TN - Tunisia 4
AL - Albania 3
BW - Botswana 3
CI - Costa d'Avorio 3
CY - Cipro 3
HN - Honduras 3
IR - Iran 3
LU - Lussemburgo 3
MY - Malesia 3
OM - Oman 3
PA - Panama 3
RO - Romania 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BO - Bolivia 2
BS - Bahamas 2
BY - Bielorussia 2
BZ - Belize 2
CH - Svizzera 2
DK - Danimarca 2
EU - Europa 2
GA - Gabon 2
GE - Georgia 2
GT - Guatemala 2
KG - Kirghizistan 2
LB - Libano 2
LV - Lettonia 2
LY - Libia 2
MD - Moldavia 2
MG - Madagascar 2
PT - Portogallo 2
RS - Serbia 2
RW - Ruanda 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AD - Andorra 1
AM - Armenia 1
AO - Angola 1
BF - Burkina Faso 1
Totale 27.573
Salva come PNG Salva come JPEG
Città #
Hong Kong 10.993
Ann Arbor 1.422
Singapore 924
Chandler 730
Princeton 707
Wilmington 661
Jacksonville 658
Dallas 499
Ashburn 436
Dublin 271
Dong Ket 270
Woodbridge 233
Houston 229
Beijing 221
Nanjing 156
Izmir 153
Moscow 146
Andover 141
Boardman 127
Ho Chi Minh City 113
Pellezzano 109
Naples 106
Dearborn 93
Los Angeles 92
Salerno 90
São Paulo 69
New York 63
Norwalk 56
The Dalles 56
Düsseldorf 55
Munich 55
Fairfield 54
Hanoi 51
Nanchang 49
Changsha 47
Hebei 46
Shenyang 45
Redwood City 41
Warsaw 40
Montreal 38
Tallinn 38
Jiaxing 36
Tokyo 36
Rome 33
Pune 32
Nuremberg 30
Rio de Janeiro 28
Santa Clara 28
Mestre 27
Brooklyn 25
Belo Horizonte 24
San Francisco 24
Atlanta 23
Council Bluffs 23
Boston 22
Seoul 22
Amsterdam 21
Brno 21
Seattle 21
West Jordan 21
Brasília 19
Chennai 19
Denver 19
Orem 18
Stockholm 18
Curitiba 17
Johannesburg 17
Milan 17
Turku 17
Washington 17
Auckland 16
Columbus 16
Tianjin 16
Poplar 15
Porto Alegre 15
Chicago 14
San Diego 14
Sydney 14
Campinas 13
Casoria 13
Guarulhos 13
Helsinki 13
Lappeenranta 13
Lecce 13
Phoenix 13
Ribeirão Preto 13
Buenos Aires 12
Guayaquil 12
Haiphong 12
London 12
Ankara 11
Brisbane 11
Cambridge 11
Fort Worth 11
Guangzhou 11
Melbourne 11
Shanghai 11
Vienna 11
Pompei 10
Hải Dương 9
Totale 21.437
Salva come PNG Salva come JPEG
Nome #
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables 1.172
Caregivers’ Burden in Parkinson’s Disease: A Study on Related Features and Attachment Styles 1.028
Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients 931
Sex Differences in Parkinson’s Disease: From Bench to Bedside 631
Distinctive speech signature in cerebellar and parkinsonian subtypes of multiple system atrophy 584
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 561
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 523
Gender differences in microRNA expression in levodopa-naive PD patients 519
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 483
Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy 443
Fist-Palm Test (FiPaT): a bedside motor tool to screen for global cognitive status 366
Energy expenditure, body composition and dietary habits in progressive supranuclear palsy 340
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: Data from the Campania Rare Disease Registry 333
Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review 312
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 308
Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson'sdisease in Italians 304
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 297
Magnetic resonance T1w/T2w ratio and voxel-based morphometry in multiple system atrophy 292
A novel phenotype in an Italian family with a rare progranulin mutation 279
Caregivers Burden: Risk and Related Psychological Factors in Caregivers of Patients with Parkinson’s Disease 277
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 266
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 248
Long-Range Auditory Functional Connectivity in Hearing Loss and Rehabilitation 237
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 204
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 201
Identifying Correlations among Biomedical Data through Information Retrieval Techniques 194
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 192
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 189
Twenty-four novel mutations in Wilson disease patients of predominantly Italian origin 176
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 174
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 168
Postganglionic sudomotor denervation in patients with multiple system atrophy. 166
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 162
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 159
A critique of the second consensus criteria for multiple system atrophy 152
Cerebellar ataxia associated with subclinical celiac disease responding togluten-free diet 149
Investigating the prevalence of MFN2 mutations in amyotrophic lateral sclerosis: insights from an Italian cohort 147
Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study 144
Progression of multiple system atrophy (MSA): a prospective natural history studyby the European MSA Study Group (EMSA SG) 142
Brain anatomical substrates of mirror movements in Kallmann syndrome. 142
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 141
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 139
A window into the mind-brain-body interplay: Development of diagnostic, prognostic biomarkers, and rehabilitation strategies in functional motor disorders 134
Serum miR-30c-5p is a potential biomarker for multiple system atrophy 133
Increased bilirubin levels in de novo Parkinson's disease 130
The natural history of multiple system atrophy: A prospective European cohort study 128
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 127
Quitting smoking: An early non-motor feature of Parkinson's disease? 122
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 122
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 120
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 120
Caregivers Burden: Risk and Related Psychological Factors in Caregivers of Patients with Parkinson’s Disease. ICGBD 2022 : International Conference on Global Burden of Disease 120
Sindromi parkinsoniane 115
Behavioural sensitization in 6-hydroxydopamine-lesioned rats is related to compositional changes of the AP-1 transcription factor: evidence for induction of FosB- and JunD-related proteins. 115
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 115
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 114
Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy 114
A genome-wide association study in multiple system atrophy 113
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 113
Adult-onset familial laryngeal abductor paralysis, cerebellar ataxia, and puremotor neuropathy 113
The development of appropriate strategies and methods for mutation analysis in the ATP7B gene 112
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 112
Cortical pattern of reduced perfusion in hearing loss revealed by ASL-MRI 112
The alpha-synuclein gene in multiple system atrophy 108
Adult-onset pure tic disorder after post-traumatic hypoxic lesions of the globus pallidus 108
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 108
The accuracy of the arginine growth hormone test in parkinsonism. 107
PINK1 heterozygous rare variants: Prevalence, significance and phenotypic spectrum 107
Gender and non motor fluctuations in Parkinson's disease: A prospective study 104
The relevance of gender in Parkinson's disease: a review 102
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 101
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 100
Bilirubin and Uric Acid: Two Different Anti-oxidants in Parkinson’s Disease 100
Effects of gender on cognitive and behavioral manifestations in multiple system atrophy 100
GBA-Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort 99
On the relationship between side of onset and cognition in Parkinson disease 98
MDS PSP criteria in real-life clinical setting: Motor and cognitive characterization of subtypes 98
Early MRI findings in acquired hepatocerebral degeneration. 97
Olfactory dysfunction in Parkinsonism caused by PINK1 mutations 96
Myocardial 123I-metaiodobenzylguanidine scintigraphy in patients with homozygous and heterozygous parkin mutations 95
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 94
“Response to Apomorphine in early Parkinson’s disease”. 94
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 93
Cognitive correlates of “pure apathy” in Parkinson's disease 93
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 92
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 91
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 90
The arginine growth hormone stimulation test in bradykinetic-rigid parkinsonisms 89
Cross-modal connectivity effects in age-related hearing loss 89
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness aspresenting symptoms of PARK-2 88
Parkinson’s disease and the spectrum of Lewy body disease 88
Bipolar Disorder and Parkinson’s Disease: A 123I-Ioflupane Dopamine Transporter SPECT Study 88
The contribution of white matter changes to clinical phenotype in progressive supranuclear palsy 87
Uric acid relates to dopamine transporter availability in Parkinson's disease. 87
Observational study of sleep-related disorders in Italian patients with Parkinson's disease: usefulness of the Italian version of Parkinson's disease sleep scale. 87
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 87
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 87
Comparative cognitive and neuropsychiatric profiles between Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy 87
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 86
Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy 86
Totale 19.890
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.556
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.556
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021801 0 0 0 0 0 80 131 14 120 3 131 322
2021/20221.112 5 7 5 6 13 4 24 37 171 160 136 544
2022/20231.846 209 129 69 174 257 412 14 161 284 11 89 37
2023/20241.225 67 153 62 93 51 136 61 120 87 79 110 206
2024/20253.209 147 35 65 158 159 318 418 342 507 303 379 378
2025/202614.763 3.032 5.189 4.284 697 1.263 298 0 0 0 0 0 0
Totale 28.213